Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för fadrozole. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

39 träffar

Bibliografisk träff 2006-04-01

Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis.

Voets M, Antes I, Scherer C, Müller-Vieira U, Biemel K, Marchais-Oberwinkler S, Hartmann RW.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm060055x

Bibliografisk träff 2005-10-01

Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis.

Voets M, Antes I, Scherer C, Müller-Vieira U, Biemel K, Barassin C, Marchais-Oberwinkler S, Hartmann RW.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm0503704

Bibliografisk träff 2005-03-01

Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase.

Ulmschneider S, Müller-Vieira U, Klein CD, Antes I, Lengauer T, Hartmann RW.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm0492397

Bibliografisk träff 2005-03-01

Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase.

Ulmschneider S, Müller-Vieira U, Mitrenga M, Hartmann RW, Oberwinkler-Marchais S, Klein CD, Bureik M, Bernhardt R, Antes I, Lengauer T.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm049600p

Bibliografisk träff 2001-03-01

A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.

Recanatini M, Bisi A, Cavalli A, Belluti F, Gobbi S, Rampa A, Valenti P, Palzer M, Palusczak A, Hartmann RW.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm000955s

Bibliografisk träff 1998-05-01

Design and synthesis of a new type of non steroidal human aromatase inhibitors.

Sonnet P, Guillon J, Enguehard C, Dallemagne P, Bureau R, Rault S Auvray P, Moslemi S, Sourdiane P, Galopin S, Séralini GE.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/s0960-894x(98)00157-7

Bibliografisk träff 1995-06-01

Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.

Hartmann RW, Bayer H, Grün G, Sergejew T, Bartz U, Mitrenga M.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm00012a009

Bibliografisk träff 1991-02-01

Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease.

Browne LJ, Gude C, Rodriguez H, Steele RE, Bhatnager A.

J Med Chem · journal article · DOI 10.1021/jm00106a038

Bibliografisk träff 1990-11-01

Mechanism and inhibition of cytochrome P-450 aromatase.

Cole PA, Robinson CH.

J Med Chem · research support, u.s. gov't, p.h.s.; review; journal article · DOI 10.1021/jm00173a001